{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:00:29Z","timestamp":1785312029601,"version":"3.55.0"},"reference-count":10,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.p7","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:57:24Z","timestamp":1785236244000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","unstructured":"1. Haute Autorit\u00e9 de Sant\u00e9 (HAS). Transplantation r\u00e9nale: acc\u00e8s \u00e0 la liste d'attente nationale. Service Bonnes pratiques professionnelles. December 2015. https:\/\/www.has-sante.fr\/jcms\/c_1751188\/fr\/transplantation-renale-acces-a-la-liste-d-attente-nationale"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Babak J. Orandi, Xun Luo, Allan B. Massie, et al. Survival benefit with kidney transplants from HLA-incompatible live donors. N Engl J Med. 2016;374(10):940-950. doi:10.1056\/NEJMoa1508380","DOI":"10.1056\/NEJMoa1508380"},{"key":"ref2","unstructured":"3. Alexandre Loupy. R\u00f4le pronostic des anticorps anti-HLA en transplantation r\u00e9nale: approches en population. M\u00e9decine humaine et pathologie. Universit\u00e9 Ren\u00e9 Descartes, Paris V, 2014. Fran\u00e7ais. https:\/\/theses.hal.science\/tel-01195994\/"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Han DJ, ed. Kidney Transplantation in Sensitized Patients. Springer Nature Singapore; 2020. https:\/\/doi.org\/10.1007\/978-981-10-7046-4_1","DOI":"10.1007\/978-981-10-7046-4_1"},{"key":"ref4","unstructured":"5. Kumar A, Mohiuddin A, Sharma A, El Kosi M, Halawa A. An update on crossmatch techniques in transplantation. J Kidney. 2017;3(4):160. doi:10.4172\/24721220.1000160"},{"key":"ref5","unstructured":"6. Besma SIFI, Me\u00e7abih F. Etude des facteurs de risque associ\u00e9s \u00e0 la pr\u00e9sence de DSA (donor-specific antibodies) en pr\u00e9 et postgreffe r\u00e9nale. M\u00e9moire de fin de r\u00e9sidanat en immunologie. Institut Pasteur Alger; 2019\/2020."},{"key":"ref6","unstructured":"7. Agence de la biom\u00e9decine. Programme de greffe - Rein. Rapport annuel 2021."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Lentine KL, Smith JM, Lyden GR, et al. OPTN\/SRTR 2023 Annual Data Report: kidney. Am J Transplant. 2025;25(2S1):S22-S137. doi:10.1016\/j.ajt.2025.01.020","DOI":"10.1016\/j.ajt.2025.01.020"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Bestard O, Couzi L, Crespo M, Kessaris N, Thaunat O. Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group. Transpl Int. 2021;34(6):1005-1018. doi:10.1111\/tri.13874","DOI":"10.1111\/tri.13874"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Furian L, Bestard O, Budde K, et al. European consensus on the management of sensitized kidney transplant recipients: a Delphi study. Transpl Int. 2024;37:12475. doi:10.3389\/ti.2024.12475","DOI":"10.3389\/ti.2024.12475"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:08:41Z","timestamp":1785308921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/231\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":10,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.p7","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}